Skip to content

Understanding the evidence for medical cannabis treatments

14 August 2019

People living with complex conditions and doctors prescribing treatments for patients have many questions about medical cannabis. Perhaps one of the biggest questions is if medical cannabis medicine works, and how well the evidence supports this.

What’s the evidence for the effectiveness of cannabis as a medicine?

When it comes to the evidence of the efficacy of medical cannabis treatments, we can class it as strong, mild to moderate and limited. There is strong evidence for the effectiveness of medical cannabis for anti-nausea in chemotherapy and radiotherapy, epilepsy and seizures and there is moderate evidence of its reliability for treating addiction and gastrointestinal conditions. 

Strong evidence

There is a wealth of research backing the use of medical cannabis in the treatment of conditions and symptoms including: 

  • Medical cannabis for nausea in chemotherapy and radiotherapy
  • Medical cannabis treatments for antispasmodic activity
  • Medical cannabis for Tourette’s and tics
  • Medical cannabis-based treatments for epilepsy, specifically Dravet Syndrome.

Moderate evidence 

Medical cannabis is also useful for the treatment of these conditions, and many case studies and patient testimonials support it, but the evidence backing it is not as strong. The conditions and symptoms suitable for medical cannabis treatment are as follows;

  • Medical cannabis for addiction
  • Cannabis-based medicines for mood stabilisation
  • Medical cannabis for gastrointestinal conditions
  • Medical cannabis treatments for Autism

Limited evidence 

There is a growing range of case studies demonstrating positive patient experiences of the following conditions and symptoms, but not as much evidence to the effectiveness of medical cannabis in treating the following conditions:

  • Medical cannabis for motor neurone disease 
  • Cannabis-based medicines Huntington’s and other physical tremor and spasticity symptoms

Further emerging research is ongoing about the usefulness and applicability of medical cannabis in treating ailments such as cancer-related treatments including post-operative and surgery-related nausea and post-traumatic stress disorder (PTSD). 

The latest evidence for medical cannabis treatment can be found via the Evidence Base at The Academy of Medical Cannabis. 

Become a patient at Lyphe

If you are considering medical cannabis as a treatment option for yourself or for a family member, the specialists from Lyphe can provide expert guidance, consultations and treatment. 

You may want to read the FAQs and Information for Doctors for more information about becoming and referring a patient to Lyphe. Click here to book an appointment with one of our specialists. 

Author: Bojan
Author page

Bojan Ambrus, Head of Marketing & Digital Product at Lyphe Group, is a data-driven growth marketing professional with over 15 years of rich experience. His background includes roles such as Head of Marketing at and growth marketing roles in various enterprises, startups, and scale-ups. His expertise in building and positioning businesses is particularly valuable in the cannabis sector, where he navigates its complexities and regulatory challenges. His strategic marketing insights make Bojan a key player in shaping Lyphe Group's marketing and digital product strategies.

Latest posts

Become a patient today

Ready to start your journey?

Check if you are eligible
Start your journey in getting treated with medical cannabis
Get Started
Speak to an advisor
Free appointment with our expert Patient Advisor
Speak to an advisor